WASHINGTON TRUST Co Buys 3,962 Shares of Cigna Group $CI

WASHINGTON TRUST Co grew its stake in Cigna Group (NYSE:CI) by 297.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,296 shares of the health services provider’s stock after purchasing an additional 3,962 shares during the quarter. WASHINGTON TRUST Co’s holdings in Cigna Group were worth $1,458,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Cigna Group by 11.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock valued at $13,039,000 after purchasing an additional 4,738 shares in the last quarter. Providence Capital Advisors LLC lifted its holdings in shares of Cigna Group by 1,016.8% in the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock valued at $2,453,000 after purchasing an additional 7,748 shares in the last quarter. Caprock Group LLC bought a new position in shares of Cigna Group in the third quarter valued at approximately $4,124,000. National Pension Service lifted its holdings in shares of Cigna Group by 3.2% in the third quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock valued at $197,091,000 after purchasing an additional 21,203 shares in the last quarter. Finally, Banco Bilbao Vizcaya Argentaria S.A. lifted its holdings in shares of Cigna Group by 13.5% in the third quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock valued at $9,839,000 after purchasing an additional 4,066 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of CI opened at $277.08 on Friday. The firm has a market cap of $73.30 billion, a PE ratio of 11.75, a PEG ratio of 1.00 and a beta of 0.30. The stock’s fifty day moving average price is $278.32 and its two-hundred day moving average price is $276.88. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities research analysts forecast that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is presently 26.45%.

Insider Activity at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 205,904 shares of company stock worth $60,277,068. 0.60% of the stock is owned by company insiders.

Analyst Ratings Changes

CI has been the topic of a number of recent analyst reports. UBS Group lifted their price target on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Royal Bank Of Canada lifted their price target on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a report on Friday, May 1st. Guggenheim lifted their price target on Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, May 4th. TD Cowen lifted their price target on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, February 9th. Finally, Morgan Stanley lifted their price target on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $339.50.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.